Evidence map›Paper›PMID 39803030›Full record

ArticleCureus2024

Atypical Adult-Onset IgA Vasculitis With Extremely Rare Complications Including Diffuse Alveolar Hemorrhage, Heart Failure, and Stroke.

Mai Motojima, Yuki Tanabe, Fumihiko Makino, Hitoshi Suzuki, Shigeki Tomita, Shinichi Sasaki, Kazuhisa Takahashi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mai MotojimaDepartment of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, JPN.
Yuki TanabeDepartment of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, JPN.
Fumihiko MakinoDepartment of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, JPN.
Hitoshi SuzukiDepartment of Nephrology, Juntendo University Faculty of Medicine, Tokyo, JPN.
Shigeki TomitaDepartment of Pathology, Juntendo University Urayasu Hospital, Chiba, JPN.
Shinichi SasakiDepartment of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, JPN.
Kazuhisa TakahashiDepartment of Respiratory Medicine, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA vasculitis (IgAV) generally occurs in young people and presents with a tetrad of symptoms: purpura, abdominal pain, arthralgia, and nephritis. However, it may have an atypical course without the typical tetrad. Diffuse alveolar hemorrhage (DAH), heart failure, and stroke are known complications of IgAV but are all very rare. We herein report a case of adult-onset IgAV that developed simultaneously with these rare complications without the typical tetrad. A 31-year-old man without any medical history presented with fever and blood-tinged sputum. Two months later, these symptoms worsened, and he was admitted to the hospital with DAH, nephritis, heart failure, and stroke. Initially, these symptoms were considered indicative of vasculitis syndrome, and he was finally diagnosed with IgAV based on the results of a renal biopsy. The treatment was successful with corticosteroids alone. IgAV should, therefore, be considered in the differential diagnosis when a patient presents with vasculitis syndrome, even with an atypical course.

Indexed as

cardiac magnetic resonancecmrdahdiffuse alveolar hemorrhageiga nephropathyigaviga vasculitis

Identifiers

PMID39803030
PMCPMC11724717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.